ELACESTRANT | ELACESTRANT | ATC L02BA04
GENITO ESTROGEN RECEPTOR ANTAGONIST TREATMENT OF POSTMENOPAUSAL WOMEN OR ADULT MEN WITH ERPOSITIVE HER2-NEGATIVE ESR1-MUTATED ADVANCED OR METASTATIC BREAST CANCER | ORAL | Cmax 259.5 NANOMOLAR Tmax 2.5 HOUR F 10 PERCENT VD 5800 LITER PPB 99 PERCENT Cl 186 LITER / HOUR HT 40 HOUR SOLUBILITY FREELY SOLUBLE IN 0.01N HCL | ESTROGEN RECEPTOR ALPHA PDB 7TE7 (ESTROGEN RECEPTOR ALPHA LIGAND BINDING DOMAIN IN COMPLEX WITH RAD1901) LIGAND CODE = I0V (link to the list of PDB complexes) Download experimental 3D coordinates of I0V with added hydrogens | Estrogen Receptor Alpha ESR1 UNIPROT P03372 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |